25.12.2014 Views

Joint Annual Research Report 2005 - The Royal Marsden

Joint Annual Research Report 2005 - The Royal Marsden

Joint Annual Research Report 2005 - The Royal Marsden

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IMAGING RESEARCH & CANCER DIAGNOSIS – MAGNETIC RESONANCE<br />

Figure 2. A representation of a<br />

tumour or tissue displaying<br />

heterogeneous cellularity. <strong>The</strong><br />

mean path length ‘L’ travelled by<br />

protons in the extracellular fluid<br />

within a specific observation time is<br />

much greater in regions of low<br />

cellularity where random motion is<br />

not impeded by the presence of<br />

cellular membranes.<br />

L<br />

L<br />

proton<br />

highly cellular region<br />

mean path length L<br />

proton path<br />

Imaging tissue cellularity<br />

and cell death<br />

Diffusion-weighted MRI<br />

Diffusion-weighted magnetic<br />

resonance imaging (DW-MRI)<br />

provides image contrast through<br />

measurement of the properties<br />

of water within tissues. In a highly<br />

cellular tissue, water cannot diffuse<br />

far during the MR observation<br />

period without being blocked by<br />

cell membranes (see Figure 2).<br />

Conversely, in cystic or necrotic<br />

tissues with fewer structural barriers,<br />

the diffusional path-length of<br />

extracellular water is longer. Apparent<br />

diffusion coefficient (ADC) maps,<br />

derived from DW-MRI, therefore<br />

provide a non-invasive measure of<br />

cellularity. In cancer imaging this<br />

has potential for diagnosis, treatment<br />

planning and monitoring response.<br />

This approach is proving valuable,<br />

as changes in ADC values are<br />

measurable earlier than conventional<br />

imaging response indicators.<br />

DW-MRI can be exploited to<br />

improve tumour detection<br />

and differentiate benign from<br />

malignant lesions.<br />

DW-MRI and tumour<br />

detection<br />

In prostate cancer, we have shown<br />

that the addition of DW-MRI<br />

identifies tumour lesions with greater<br />

A<br />

certainty than using conventional<br />

imaging alone (see Figure 3).<br />

Additionally, the ADC values of<br />

malignant prostate nodules appear<br />

to be lower than those of nonmalignant<br />

prostate nodules; we are<br />

validating our results with<br />

prostatectomy (this work is funded<br />

by the <strong>Royal</strong> <strong>Marsden</strong> Hospital<br />

Charity). We are also exploring ADC<br />

as a measure of tumour aggressiveness<br />

in patients opting to have their<br />

prostate cancer actively monitored<br />

(Cancer <strong>Research</strong> UK funded<br />

surveillance programme led by<br />

B<br />

Figure 3. Primary prostate cancer:<br />

Transverse T2W image (FSE 2096/90 msec [TR/effective TE] (A) and an isotropic ADC map (B)<br />

at the same level through the prostate apex calculated from images (b = 0, 300, 500, 800<br />

s/mm2) with diffusion weighted gradients sensitised in 3 planes. <strong>The</strong> tumour which is poorly<br />

seen as an ill defined low signal intensity area on T2W (arrow) is clearly demarcated as an<br />

area of restricted diffusion (arrow) on the ADC map.<br />

36

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!